Revision history of "Anticomplement C5 treatments together with eculizumab throughout three installments of critical COVID19"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 11:24, 24 April 2024‎ Thumbfreeze58 (Talk | contribs)‎ . . (3,660 bytes) (+3,660)‎ . . (Created page with "7% (3/18) associated with people. Through per-protocol examination, such as only people who finished treatment method, normalization of ALP happened 27.7% (3/11) from full wee...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Anticomplement_C5_treatments_together_with_eculizumab_throughout_three_installments_of_critical_COVID19"